ERDMANN DESIGN

HUMAN CENTERED DESIGN
SWITZERLAND

YES!
WE UNDERSTAND YOU.

INVESTORS

INVESTORS

Today life science investments are in high demand. Erdmann Design takes a vital role in life science investments: Through active involvement early in the product and service development process we spark start-up companies’ early growth.

MEDICAL

MEDICAL

Medical doctors and life science experts are seeking to bring their own product ideas to the market. The patient is their focus: Doctors and other experts address the patient’s complete health experience not just their symptoms.

EXECUTIVE

EXECUTIVE

Swiss industrial partners strive for high manufacturing quality as well as clinical efficacy in their work. As an innovation partner we collaborate to find solutions, including solving regulatory issues. We build a reliable design and production network to bring the product from idea to realisation.

EXPERTS

EXPERTS

Success in medical design, engineering and manufacturing teams requires experienced project leaders. Our goal: Synthesizing experience and creating opportunities for the company. 

USERS

USERS

In addition to ease of use, clinical efficacy and safety, we designers are looking for the good solution. This solution lowers costs and provides patient satisfaction. 

«Erdmann Design’s active involvement early in the product and service development process is an absolute benefit for Naviswiss. Erdmann creates intelligent medical products and drives innovation.»

Christian Walsoe, CFO, Member of the board, Naviswiss AG, Switzerland

Mindmap

NAVISWISS

New Navigated Surgery  
Switzerland

UNDERSTANDING THE DESIGN CONTEXT

What users believe they know about a product strongly impacts how they use it. A mental model is based on belief, not facts.


Designing for others means drawing on knowledge of mental models and requires entering users‘ understanding.

Raimund Erdmann

«I was surprised to find out how similar the design process is to the patient history and documentation which we surgeons use to exchange experiences among each other. Since then we have worked together with designers.»

Prof. Dr. Hans-Florian Zeilhofer, Founder Mininavident AG

Mindmap

DENACAM 
3D realtime navigation system for implantology
by Mininavident AG Switzerland

ON THE LEVEL OF USE 

The aim of design is to encourage interfaces that move effortlessly from recognition, to exploration, to reliance, until the user is satisfied.


Affordings include direct perceptions: bendability, twistability, pushability, rotatability, graspability, steerability, heaviness, and danger.


Affordances are irreducible cultural habits and difficult to modify. Designers should make them easily recognizable and bring forth the consequences that users expect, ideally without unnecessary constraints.

Raimund Erdmann

«The creative impulses of the Erdmann Design Team are crucial for our success. They think up surprising solutions!»

Ueli Breitschmid, Owner and CEO Curaden AG, Switzerland

Mindmap

CURAPROX  
HYDROSONIC ORTHO
Hydrodynamic sonic toothbrush

MULTISENSORY REDUNDANCY

The design of products and interfaces must assure that all senses are accounted for.


In designing a product, attention to all senses provides the end-user with a richer experience.


Our process includes testing within the context of use. Testing a product in a real-life light and acoustic situation is crucial to the understanding of the user’s behavior and interaction.

Raimund Erdmann

«Humans learn all the time. Meanings change in use. Users should be able to enter the interface of a system on any skill level and advance their competencies at their own pace. Users should also be permitted to introduce variations on successful scenarios, finding shortcuts, economizing efforts, and having fun.

Stryker’s navigation must acknowledge what users know today, but be designed for learnability.»

Project team leader at Stryker

Mindmap

STRYKER   
PROFESS Navigation System
Pattern Recognition Optics for Functional 
Endoscopic Sinus Surgery

ROBUST SYSTEM

An ideally robust system in one in which most foreseeable mishaps are prevented. When something unintended does slip through, it provides an opportunity for learning something new.


It is a challenge for designers to anticipate what the users of a product might do and provide the necessary clues to prevent interfaces from being disrupted, or worse, causing harm.


Early prototyping with input from medical disciplines and end-users make risks visible, understandable and solvable.

Raimund Erdmann

«Data availability is growing at an exponential rate. Data for patients, for physicians, and for manufacturers. As an industry, we have to get better at using that fragmented data to its full potential by integrating it into new therapeutic concepts to improve outcomes for patients. At the same time, we need to ensure we comply fully with data-privacy law and regulations.»

Cédric Gysel, Human Centered Design Innovation Lab & Make Space Switzerland

Mindmap

JANSSEN    
Practice injecting with this reusuable training device. by Cilag, Janssen  
Switzerland

INTERACTION FEEDBACK

Feedback on any user action should be as immediate and as direct as possible.

Usability workshops with stakeholders to validate the systems interfaces and interactions will give us the necessary relevance to the task.

Raimund Erdmann

Go to article: Home | Getting PersonalGo to article: Scandinavian Health Ltd. Company InsightGo to article: Scandinavian Health Ltd.Go to article: In this issueGo to article: International Cannabis and Cannabinoid Institute (ICCI) Company InsightGo to article: International Cannabis and Cannabinoid Institute (ICCI)Go to article: ContentsGo to article: Novo NordiskGo to article: NewsGo to article: PhoenixGo to article: The Pharma Industry BriefingGo to article: Nelson Lab Company InsightGo to article: Nelson LabsGo to article: Manufacturing personalised meds: what needs to change?Go to article: Molnar Company InsightGo to article: MolnarGo to article: Selling cells: the economics of CAR-T therapyGo to article: Wilhelm Haselmeier GmbH & Co KG Company InsightGo to article: Wilhelm Haselmeier GmbH & Co. KGGo to article: Using AI to personalise drug combination therapyGo to article: NSFGo to article: Is the microbiome as important for precision medicine as genetics?Go to article: Nipro PharmaPackagingGo to article: A summer of manufacturing disasters for Chinese pharmaGo to article: CapsugelGo to article: EndocaGo to article: ContraFect’s Staph infection drug may succeed in trial but caveats remainGo to article: Dow Europe GmbH Company InsightGo to article: Dow Europe GmbHGo to article: Why are novel therapies for glioblastoma patients not gaining approvals?Go to article: Lubrizol Life SciencesGo to article: QualiMetriXGo to article: CAR-T approved in Europe but NICE verdict is divided: what happens next?Go to article: Palleos healthcare GmbH Go to article: Daiichi JitsugyoGo to article: EventsGo to article: Nemera Company InsightGo to article: Erdmann Design SwitzerlandGo to article: Next issueGo to article: NemeraGo to article: Plastiape Go to article: General Electric Healthcare